Short answer
In regulated manufacturing and laboratories, SOPs are compliance documents: they are approved, controlled, and tied to deviation and record-keeping duties. That tends to make them structured and well versioned, and also more sensitive and harder to license. Evaluate approval status, version control, deviation linkage, signatures and third-party content before buying, and do not assume the text shows how the work is done.
Why regulated SOPs are a different asset
A procedure in a pharmaceutical plant or a nonclinical testing laboratory is not just advice to staff; it is typically part of a quality system that a regulator can inspect. US drug production rules expect written procedures for production and process control, with procedures and changes drafted, reviewed and approved by the relevant units and by the quality control unit, followed and documented at the time of performance, with any deviation recorded and justified (FDA, 21 CFR 211.100). The good laboratory practice regulation sets comparable expectations for testing facilities; it requires an approved written protocol for each study and requires deviations from SOPs to be authorized by the study director and recorded in the raw data (FDA, 21 CFR Part 58). Other sectors have their own regimes.
For a buyer, the consequences are mixed. The documents are often well structured, carefully versioned and linked to deviation records, which can make them strong inputs for grounding and for change-aware evaluation. They are also usually treated as confidential, written to survive audit, and shaped by compliance language that may hide real practice. This is not legal advice, and what any supplier must keep varies by sector and product.
This page is a checklist for evaluating an offer. For lab-specific content, see laboratory SOPs; for a general corpus review, the SOP corpus evaluation checklist applies first.
The evaluation checklist
Use the table as an Illustrative template: criteria and evidence are examples to adapt, and the pass condition is yours to set.
| Check | Pass condition | Evidence to request | Red flag |
|---|---|---|---|
| Approval status | Every document is the approved, effective version | Controlled-copy marker or approval page | Drafts mixed with effective versions |
| Version chain | Superseded versions are identified and dated | Revision table; see SOP revision histories | Only the latest copy, with unknown age |
| Deviation linkage | Deviations can be tied to the SOP step | Deviation record format | Deviation records absent or inseparable from batch data |
| Signatures | Personal names and signatures are handled | Redaction plan | Signature images embedded in scans |
| Third-party text | Vendor, customer or regulator text is identified | Document authorship list | Pasted instrument-maker manuals |
| Product identity | Product, batch and customer names are removable | Redacted sample | Product names built into step logic |
| Scope | The sector, process and site are stated | Document list | "Pharma SOPs" with no process detail |
Checks in more detail
Approval and effectivity. An SOP that was approved but never made effective, or one withdrawn, is not a procedure anybody followed. Ask for the effective date and the status field, and exclude documents whose status you cannot establish.
Deviation linkage. The regulations above treat deviations as recorded events. If a supplier can pair SOP steps with anonymized deviation categories, you gain labeled examples of where procedures fail. If deviations are bundled with batch records, they may include product and batch identifiers that make release difficult; ask early. Deviation reports covers how to use them.
Compliance language. Regulated SOPs often say "ensure", "verify" and "as per specification" without describing the verification. The text is correct for audit and thin for planning. Count how many steps have an objective acceptance criterion; the rest cannot become success tests without extra work.
Cross-references. A regulated SOP typically points to forms, specifications and other SOPs. Ask whether the referenced documents are in scope, since a procedure that leans on missing attachments is not self-contained.
What the text cannot support
These documents show what the quality system requires, not what operators do. A procedure being approved and followed on paper does not show that the sequence on the floor matches it. Compliance text also contains no motion, force, perception or timing information, so it cannot train a humanoid's control; robot or teleoperation data is required for that, with procedures supplying structure, order and acceptance criteria only.
There are further limits on what you may infer:
- No evidence of compliance for a robot. Training on regulated procedures does not demonstrate that a robot, or its operation, meets any regulatory expectation. Validation is a separate process owned by the operator, and whether any regulation applies to a robot's use is a question for the operator's counsel and regulatory teams.
- Sensitive process knowledge. The most informative parameters are the ones most likely to be removed. Heavy redaction can leave a sequence with no discriminating content; see redacting SOPs.
- Narrow coverage. A dataset drawn from a single product line or site overrepresents that process.
- Cleanroom and controlled-area conditions. Gowning, material flow and environmental controls are specific to the area and may not generalize to ordinary workplaces.
Permissions and provenance
The licensor must be able to grant the rights, and in regulated settings that often involves more than one team. Ask whether quality, legal and the product owner have agreed to the release. Customers may have confidentiality terms over processes made for them, and some procedures embed text from pharmacopoeias, standards bodies or instrument makers. Redacting a product name does not settle who may license the document. Who owns a procedure and SourceX's own licensing terms page frame the questions; neither replaces counsel.
Questions to ask suppliers
- Are the documents approved and effective, and how is status shown on the copies provided?
- Can you supply a revision table for each document?
- Which SOPs reference forms, specifications or other SOPs, and are those referenced documents included?
- Are deviation or exception records available in a form without batch or product identifiers?
- Who signed each document, and how will signatures be removed?
- Which parts come from a customer, regulator, instrument maker or standards body?
- Has quality, legal and the product owner approved release for AI training use?
- Is the SOP set from one product line or several?
If your team is still defining which regulated procedures would help, write it up through a buyer request so potential sources can be investigated against it.
Discuss your requirements
Describe the sector, document types, version depth and rights terms you need. SourceX reviews the requirement and follows up about potential sources among US businesses; a request does not guarantee a match, and nothing is contracted until a supplier agrees. See the procedures hub and the humanoid training-data section for wider context.
Explore sourcing and licensing options with SourceX.
Sources
- 21 CFR 211.100 Written procedures; deviations — approved procedures and recorded deviations in drug production.
- 21 CFR Part 58 - Good Laboratory Practice for Nonclinical Laboratory Studies — SOP and deviation expectations for nonclinical laboratory studies.